BETA

4 Amendments of Victor NEGRESCU related to 2016/2057(INI)

Amendment 42 #
Draft opinion
Paragraph 2
2. Considers thatere to be a need to rethink the mechanism for granting exclusive protection periods granted to pharmaceuticals through patents or other mechanisms since these currently hinder competition, lead to high prices and negatively impact access to needed medicines;
2016/10/04
Committee: JURI
Amendment 89 #
Draft opinion
Paragraph 7 e (new)
7e. Calls on the Commission to request the Member States to define public policies and produce statistical evidence on the number of chronically ill persons, broken down by illness, and the forecast for the coming 5 to 10 years;
2016/10/04
Committee: JURI
Amendment 91 #
Draft opinion
Paragraph 7 g (new)
7g. Calls on the Commission to launch discussions on devising a procedure for establishing (on the basis of age, type of chronic illness, income, etc.) the socially-disadvantaged categories to which innovative medicines could be made available, on an exceptional basis, before the patent expires;
2016/10/04
Committee: JURI
Amendment 93 #
Draft opinion
Paragraph 7 i (new)
7i. Calls on the Commission to introduce transparent mechanisms for correctly setting the price of medicines available on the market.
2016/10/04
Committee: JURI